| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |